4.3 Article

Different Definitions of Prevalent Hypertension Impact: The Clinical Epidemiology of Hypertension and Attainment of Healthy People Goals

期刊

JOURNAL OF CLINICAL HYPERTENSION
卷 15, 期 3, 页码 154-161

出版社

WILEY
DOI: 10.1111/jch.12057

关键词

-

资金

  1. Centers for Disease Control through the South Carolina Department of Health and Environmental Control [SC DHEC]
  2. State of South Carolina
  3. NIH [HL105880, NS058728, HL091841]
  4. SC DHEC, Tobacco Control and Heart Disease and Stroke Prevention
  5. Daiichi-Sankyo
  6. Medtronic
  7. Novartis
  8. Takeda

向作者/读者索取更多资源

Prevalent hypertension in National Health and Nutrition Examination Surveys (NHANES) is traditionally defined as blood pressure (BP) 140mmHg systolic and/or 90 diastolic and/or currently taking antihypertensive medications. When estimating prevalent hypertension, American Heart Association (AHA) statistical updates include the traditional definition of hypertension (tHTN) and untreated individuals with nonhypertensive BP told twice that they were hypertensive (nontraditional [ntHTN]). The characteristics of ntHTN and their impact on the clinical epidemiology of hypertension and Healthy People prevention and control goals are undefined. NHANES 19992002, 20032006, and 20072010 were analyzed. The ntHTN group was younger and had less diabetes and lower BP than the tHTN group but higher BP than the normotensive group. When classifying ntHTN as hypertensive, prevalent hypertension increased approximately 3% and control 5% to 6% across NHANES periods. In 20072010, the Healthy People 2010 goal of controlling BP in 50% of all hypertensive patientss was attained when ntHTN was classified as hypertension (56.5% [95% confidence interval (CI), 54.258.7]) and nonhypertension (51.8% [95% CI, 49.653.9]). When including ntHTN in prevalent hypertension estimates, the Healthy People 2020 goal of controlling BP in 60% of hypertensive patients becomes more attainable, whereas reducing prevalent hypertension to 26.9% (31.8% [95% CI, 30.533.1]) vs 28.7% [95% CI, 27.530.0]) becomes more challenging. J Clin Hypertens 2013;15:154-161. (C) 2012 Wiley Periodicals, Inc

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据